U.S. to resume J&J COVID-19 vaccinations despite rare clot risk
3 years, 8 months ago

U.S. to resume J&J COVID-19 vaccinations despite rare clot risk

The Hindu  

U.S. health officials lifted an 11-day pause on COVID-19 vaccinations using Johnson & Johnson's single-dose shot, after scientific advisers decided its benefits outweigh a rare risk of blood clot. But ultimately Friday, the Food and Drug Administration and Centers for Disease Control and Prevention decided that J&J's one-and-done vaccine is critical to fight the pandemic — and that the small clot risk could be handled with warnings to help younger women decide if they should use that shot or an alternative. The US decision — similar to how European regulators are rolling out J&J's shot — comes after CDC advisers earlier Friday voted 10-4 to resume vaccinations but panelists made clear that they must come with warnings about the risk. It does not absolve us from making sure that people who receive this vaccine, if they are in the risk group, that we inform them of that.” European regulators earlier this week made a similar decision, deciding the clot risk was small enough to allow the rollout of J&J's shot.

History of this topic

Why Americans are opting out of getting a COVID booster shot
1 month, 2 weeks ago
New COVID-19 vaccines targeting JN.1 variant under review by Therapeutic Goods Administration
4 months ago
‘Still not over’: WHO cautions of COVID-19 threat ahead of summer holidays after US President Joe Biden tests positive
5 months, 3 weeks ago
As COVID-19 ticks up in some places, US health officials recommend a fall vaccination campaign
6 months, 1 week ago
As COVID-19 ticks up in some places, US advisers recommend a fall vaccination campaign
6 months, 1 week ago
FDA advisers urge targeting JN.1 strain in recipe for fall’s COVID vaccines
7 months ago
2% of kids and 7% of adults have gotten the new COVID shots, US data show
1 year, 2 months ago
U.S. approves updated COVID vaccines to rev up protection this fall
1 year, 3 months ago
US approves updated COVID vaccines to rev up protection this fall
1 year, 3 months ago
FDA approves updated COVID vaccines to rev up protection this fall
1 year, 3 months ago
FDA advisers set to consider one-and-done annual covid booster plan
1 year, 11 months ago
FDA’s advisors back plan to simplify COVID-19 vaccinations
1 year, 11 months ago
As COVID-19 spikes in California, booster shots could make all the difference
2 years, 1 month ago
Explained | Can vaccine distribution be made fairer?
2 years, 1 month ago
Panel votes to add COVID shots to recommended vaccinations
2 years, 2 months ago
Panel votes to add COVID shots to recommended vaccinations
2 years, 2 months ago
Covid-19 vaccination campaign held back by poor planning, safety board finds
2 years, 2 months ago
Covid-19 vaccination campaign held back by poor planning, safety board finds
2 years, 2 months ago
First on CNN: Unvaccinated individuals 14 times more likely to get monkeypox than vaccinated, new US data shows
2 years, 3 months ago
Covid 19: If we've all been jabbed why are we still being poleaxed by the virus
2 years, 4 months ago
White House urges caution on COVID variants, pushes boosters
2 years, 5 months ago
US health officials urge booster shots as COVID variants spread
2 years, 5 months ago
Extra Covid-19 measures not yet necessary: Van Dissel
2 years, 6 months ago
WHO Says Second Booster Jab Beneficial For Vulnerable Population
2 years, 7 months ago
The AP Interview: US ‘vulnerable’ to COVID without new shots
2 years, 7 months ago
Africa's COVID vaccine production line in jeopardy
2 years, 7 months ago
J&J Covid-19 vaccine ‘limited’ to some people after clot concerns: Report
2 years, 8 months ago
FDA restricts Johnson & Johnson’s COVID-19 vaccine due to blood clot risk
2 years, 8 months ago
New COVID-19 data shows unvaccinated have 'triple' the risk of death compared with fully jabbed
2 years, 8 months ago
Rollout of fourth dose of Covid-19 vaccine being ‘kept under review’, Javid says
2 years, 9 months ago
J&J vaccine recipients were FIVE TIMES as likely to be hospitalized with Covid as Pfizer recipients
2 years, 10 months ago
Very small blood clot risk after first AstraZeneca Covid shot, say UK studies
2 years, 10 months ago
Over-50s set to be offered Covid booster vaccines this autumn
2 years, 10 months ago
Johnson & Johnson recipients can get third COVID shot in San Francisco
2 years, 11 months ago
COVID vaccines lower hospitalizations across the board, not just in the US
2 years, 11 months ago
Austria’s vaccine board recommends fourth Covid-19 jab for some
3 years ago
A million adults over 60 need a Covid booster jab appointment; 9.2 million adults left to go
3 years ago
US health experts recommend Pfizer, Moderna COVID-19 shots over J&J vaccine
3 years ago
CDC Panel Recommends Pfizer, Moderna Vaccines Over J&J Shot
3 years ago
CDC advisers review blood-clotting risk associated with J&J’s covid-19 vaccine
3 years ago
US CDC panel votes to recommend mRNA COVID-19 vaccines over J&J’s
3 years ago
NHS gives out record 611,000 jabs in a single day after bookings open to all over-18s
3 years ago
One year of vaccines: Many lives saved, many needlessly lost
3 years ago
The big vaccine pivot: Merck falters on Covid-19 shots, then makes one for rival
3 years ago
COVID-19 | Government to wait for expert view on booster dose, jabs for children
3 years, 1 month ago
WHO warns of dangers of vaccination apathy as EU chief mulls mandatory COVID-19 jabs
3 years, 1 month ago
European Union Considers Booster Doses of J&J's Covid-19 Vaccine
3 years, 1 month ago
US expands Covid-19 booster eligibility to all adults
3 years, 1 month ago
EXPLAINER: How US rules on international travel are changing
3 years, 2 months ago
Johnson & Johnson's COVID-19 vaccine is 74% effective at preventing infection, study finds
3 years, 2 months ago

Discover Related